Skip to the main content
The Crier

UK SBS Seahorse XFe96 Analyser

Your saved contracts

What the buyer wrote

There is no other instrument on the market or in development that can analyse cellular metabolism at this high level. We were one of the pioneer research groups to adopt this technology and published several papers in high impact journals, which could not have been produced without the Seahorse Technology. The Seahorse XFE is now an essential tool in cancer metabolism studies and mitochondrial toxicity research worldwide. Both these areas are priority research projects within the MRC Toxicology Unit strategic plan.

Bid for this and lost? There is a short window in which the decision can be questioned.

Awarded to

Agilent Technologies LDA UK Ltd£148.9kends (3 Jun 2022)

Details

What the buyer calls it
UK SBS Seahorse XFe96 Analyser
How they are buying
Given to one supplier, no competitionNobody else was asked, and the buyer has to be able to justify that.
Type
goods
Work starts
3 May 2017
Work ends
3 Jun 2022

Who the buyer named

Rebecca Fish was the named contact on this notice.

fmprocurement@uksbs.co.uk